Quantbot Technologies’s Odonate Therapeutics ODT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-2,300
Closed -$6K – 2075
2021
Q3
$6K Buy
+2,300
New +$7.65K ﹤0.01% 1407
2020
Q4
– Sell
-158
Closed -$2K – 1821
2020
Q3
$2K Buy
+158
New +$4.48K ﹤0.01% 1235

Other funds holding ODT

Quantbot Technologies's ODT Position: Q4 2021 in Review

Quantbot Technologies sold out of Odonate Therapeutics (ODT) in Q4 2021, closing a stake of 2,300 shares — an estimated $6K sold.

Quantbot Technologies first reported a position in ODT in Q3 2020 and held it in 2 quarters. The position peaked at $6K in Q3 2021. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.

  • Quantbot Technologies reported no remaining Odonate Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Quantbot Technologies sold 2,300 Odonate Therapeutics shares in Q4 2021, an estimated $6K.
  • Quantbot Technologies first reported a position in Odonate Therapeutics in Q3 2020 and held it in 2 quarters.
  • Quantbot Technologies's Odonate Therapeutics position peaked at $6K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Odonate Therapeutics as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.